OrbiMed’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-117,000	Closed	-$6.67M	–	123
2023 Q3	$6.67M	Hold	117,000	–	–	0.14%	90
2023 Q2	$5.97M	Buy	+117,000	New	+$5.97M	0.11%	93